Novel Chewable Pleuran-Based Supplement Decreases Respiratory Tract Infections in Children: A Randomised Controlled Trial.
- 2025-10-14
- RCT · n = 249
- Advances in therapy 42(12)
- Milos Jesenak
- Elena Prokopova
- Jan Bozensky
- Branka Bonaci-Nikolic
- Katarina Milosevic
- Katarina Stankovic
- Olivera Ostojic
- Zorica Zivkovic
- Zuzana Diamant
- Peter Kunc
- Kamil Janeczek
- Juraj Majtan
- PubMed: 41085920
- DOI: 10.1007/s12325-025-03393-3
- High evidence
- Large Human Trial
- Children
The active group experienced significantly fewer total RTIs versus placebo (2.35 ± 1.25 vs. 2.77 ± 1.78; P = 0.042), representing 15.2% reduction over 3 months.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes